** Shares of MedAdvisor MDR.AX down 5% at A$0.19
** Stock hit lowest level since Dec. 27
** Medical software co says Q2 FY25 operating revenue fell by 38.6% to A$30.8 million ($19.20 million)
** However, co expects stronger second half through diversified U.S. pipeline for various health program, others
** Stock down 11.1% this year, as of last close
($1 = 1.6044 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。